Kilroy Realty Bets on Biotech and AI Amid West Coast Office Slump
Kilroy Realty Corporation, a leading owner of office and life science properties, is navigating shifting market conditions along the US West Coast. While traditional office demand has weakened since 2023, the company's focus on specialised spaces—particularly in biotech and AI-driven sectors—sets it apart in an uncertain economy.
CEO Angela Aman leads the firm alongside a team of senior executives, including CFO Jeffrey Kuehling and Chief Investment Officer Eliott Trencher. Their strategy aims to capitalise on emerging trends reshaping commercial real estate.
The West Coast office market has faced declining demand since early 2023. Remote work policies and economic instability have pushed vacancy rates higher, especially in major cities like San Francisco and Los Angeles. Many businesses have scaled back or rethought their office needs, leaving landlords with excess space.
Despite these challenges, life science properties have held up better. Growth in biotech and pharmaceutical industries has kept demand steady for specialised labs and research facilities. Key factors driving this resilience include proximity to universities, access to venture capital, and the need for tailored infrastructure.
Kilroy Realty owns a portfolio of high-quality office and life science buildings across the West Coast and in Austin, Texas. The company's leadership—Angela Aman as CEO, alongside Jeffrey Kuehling (CFO), Eliott Trencher (Chief Investment Officer), Rob Paratte (Chief Leasing Officer), and Doug Bettisworth (Head of Investor Relations)—sees opportunity in sectors tied to AI and advanced technologies. Their approach focuses on adapting to market shifts while leveraging strengths in niche, high-demand areas.
Kilroy Realty's mix of traditional offices and specialised life science spaces positions it differently from competitors. As remote work continues to reshape demand, the company's focus on AI-aligned and biotech-driven properties may help offset broader market downturns. The coming year will test whether this strategy can sustain growth in an evolving commercial real estate landscape.
